A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas von Agulnik, M., Costa, R.L.B., Milhem, M., Rademaker, A.W., Prunder, B.C., Daniels, D., Rhodes, B.T., Humphreys, C., Abbinanti, S., Nye, L., Cehic, R., Polish, A., Vintilescu, C., McFarland, T., Skubitz, K., Robinson, S., Okuno, S., Van Tine, B.A.

Volltext